Combinations of Tri-complex KRAS(ON) Inhibitors with RAS Companion Inhibitors and Immunotherapies Improve Anti-tumor Activity and Abrogate Adaptive Resistance in Preclinical Tumor Models In Vivo

Cristina Blaj , Mariela Moreno Ayala, Avery Salmon, Marie Menard, Nataliya Shifrin, Philip Wig, Haley Courtney, Alice Kumamoto, Jacqueline AM Smith, Elsa Quintana


European Association for Cancer Research (EACR) Annual Congress 2023; June 12-15, 2023.  Poster EACR23-0610.


Return to Media Home